FAA Develops New Marijuana Standards for Pilots After Schedule III Move

FAA Partners With National Academies on Safety Review

The FAA's Office of Aerospace Medicine has engaged the National Academies of Sciences, Engineering, and Medicine to develop evidence-based marijuana standards for safety-sensitive aviation positions. The partnership was announced in a July 31 statement that explicitly ties the policy review to the DEA's April 2026 final rule moving cannabis from Schedule I to Schedule III under the Controlled Substances Act.

It's the first time a federal safety regulator has formally acknowledged the need to revise drug-testing protocols in response to rescheduling. The FAA didn't specify a timeline for new standards or whether current zero-tolerance policies would remain in effect during the review.

Agency Cites 'Normalization' Risk From Rescheduling

FAA officials stated that Schedule III placement has accelerated the 'normalization' of cannabis use, creating what the agency termed an 'operational risk' for aviation safety. The language suggests FAA leadership views rescheduling as a cultural shift that could lead more pilots and controllers to assume cannabis use is federally permissible.

Current FAA regulations are unforgiving. Pilots and air traffic controllers face immediate certificate revocation for any positive marijuana test, regardless of THC concentration or time since use. That standard hasn't changed since the agency adopted its Drug and Alcohol Testing Program in 1988, and the FAA conducts approximately 220,000 random drug tests annually across the aviation workforce.

Schedule III Status Does Not Legalize Federal Employee Use

The DEA's rescheduling decision doesn't authorize federal employees or safety-sensitive workers to use marijuana, a fact the FAA statement didn't explicitly clarify. Schedule III substances—including ketamine, anabolic steroids, and now cannabis—remain controlled and subject to prescription requirements under 21 U.S.C. § 812.

That disconnect has created confusion across federal agencies. The Department of Transportation issued guidance in May 2026 stating that DOT-regulated employees, including pilots, remain subject to zero-tolerance marijuana policies despite rescheduling. The FAA's July statement is the first indication that the agency is considering whether those standards require revision.

National Academies to Deliver Impairment Framework

The FAA tasked the National Academies with developing an impairment-based framework that accounts for THC detection windows, which can extend weeks beyond actual intoxication. Current urine-based testing can't distinguish between recent use and metabolites from consumption days or weeks earlier—a scientific limitation that has drawn legal challenges in state employment cases.

The National Academies previously examined cannabis and driving in a 2017 report that found no validated THC threshold for impairment. That report recommended further research into alternative testing methods, including oral fluid and performance-based assessments. Whether the new aviation study will explore similar alternatives remains unclear.

What Happens Next

No deadline announced. No interim policy changes signaled. Pilots and air traffic controllers remain subject to existing zero-tolerance standards pending the study's completion. For full background on federal rescheduling and its downstream effects, see the CannIntel topic hub on DEA rescheduling.

The next signal: whether other safety-sensitive federal agencies—including the Federal Railroad Administration and the Pipeline and Hazardous Materials Safety Administration—follow FAA's lead in commissioning formal reviews. Both agencies regulate drug testing under the same DOT framework.